SCHEMBL761333

SCHEMBL761333

C=C1NCCS1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL761337 0.82
SCHEMBL3817007 0.63
SCHEMBL3819741 0.62
SCHEMBL34680 0.62
SCHEMBL9935782 0.62
SCHEMBL622255 0.62
SCHEMBL1628000 0.62
SCHEMBL17102937 0.62
SCHEMBL8975369 0.62
SCHEMBL27472571 0.62 INMT (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1320880-C Improved formulation for topical non-invasive application in vivo IDEA INNOVAT DERMALE APPL GMBH (DE) 2007-06-13 CN claimed
EP-0837052-B1 BICYCLIC AMINO DERIVATIVES AND PGD 2 ANTAGONIST CONTAINING THE SAME SHIONOGI & CO (JP) 2006-08-23 EP claimed
WO-2003070239-A1 BENZYLIDENE THIAZOLIDINEDIONES AND THEIR USE AS ANTIMYCOTIC AGENTS OXFORD GLYCOSCIENCES (UK) LTD (GB) 2003-08-28 WO claimed
US-6498190-B1 TREATMENT OF NASAL OCCLUSION AND MAST CELL DYSFUNCTION DISEASES; ANTIINFLAMMATORY AGENTS SHIONOGI & CO., LTD. (JP) 2002-12-24 US claimed
US-6384075-B1 TREATING DISEASES IN WHICH MAST CELL DYSFUNCTION IS INVOLVED SHIONOGI & CO., LTD. (JP) 2002-05-07 US claimed
US-6172113-B1 Bicyclic amino derivatives and PGD2 antagonist containing the same SHIONOGI & CO., LTD. (JP) 2001-01-09 US claimed
CN-1193315-A Bicyclic amino derivatives and PGDZ antagonist containing same SHIONOGI PHARMACEUTIC K K (JP) 1998-09-16 CN claimed
EP-0837052-A1 BICYCLIC AMINO DERIVATIVES AND PGD 2 ANTAGONIST CONTAINING THE SAME SHIONOGI & CO., LTD. (JP) 1998-04-22 EP claimed
US-12410116-B2 Compounds and use thereof in methods of treatment THE UNIVERSITY OF QUEENSLAND (AU) 2025-09-09 US disclosed
US-20240002326-A1 COMPOUNDS AND USE THEREOF IN METHODS OF TREATMENT THE UNIVERSITY OF QUEENSLAND (AU) 2024-01-04 US disclosed
US-20230100768-A1 INHIBITORS OF SOX18 PROTEIN ACTIVITY FOR TREATING ANGIOGENESIS AND/OR LYMPHANGIOGENESIS-RELATED DISEASES THE UNIVERSITY OF QUEENSLAND (AU) 2023-03-30 US disclosed
WO-2023015156-A1 PYRROLOPYRIDINE-3- AND 4-CARBOXAMIDE COMPOSITIONS AND METHODS FOR CELLULAR PROLIFERATION HUDSPETH A JAMES (US) 2023-02-09 WO disclosed
EP-3210627-B1 CONJUGATES OF CELL BINDING MOLECULES WITH CYTOTOXIC AGENTS HANGZHOU DAC BIOTECH CO LTD (CN) 2022-12-21 EP disclosed
US-11434190-B2 Inhibitors of SOX18 protein activity for treating angiogenesis-and/or lymphangiogenesis-related diseases THE UNIVERSITY OF QUEENSLAND (AU) 2022-09-06 US disclosed
CN-1193315-A Bicyclic amino derivatives and PGDZ antagonist containing same SHIONOGI PHARMACEUTIC K K (JP) 1998-09-16 CN disclosed
EP-0837052-A1 BICYCLIC AMINO DERIVATIVES AND PGD 2 ANTAGONIST CONTAINING THE SAME SHIONOGI & CO., LTD. (JP) 1998-04-22 EP disclosed
CN-1097007-A Process for preparing 2-iminothiazoline derivatives and process for preparing intermediates thereof SUMITOMO CHEMICAL CO (JP) 1995-01-04 CN disclosed
US-4365989-A 2-Thiocyanomethylthio-4,4-dialkyl-5-substituted-thiazoline fungicides CHEVRON RESEARCH COMPANY (US) 1982-12-28 US disclosed
US-3943142-A Dye intermediates and their preparation and use in the synthesis of methine dyes EASTMAN KODAK COMPANY (US) 1976-03-09 US disclosed
US-3943142-A Dye intermediates and their preparation and use in the synthesis of methine dyes EASTMAN KODAK COMPANY (US) 1976-03-09 US disclosed